Li C - Search Results

1

FLT3 inhibitors in acute myeloid leukemia.

Wu M, Li C, Zhu X. Wu M, et al. Among authors: li c. J Hematol Oncol. 2018 Dec 4;11(1):133. doi: 10.1186/s13045-018-0675-4. J Hematol Oncol. 2018. PMID: 30514344 Free PMC article. Review.

2

[Construction of recombinant adenovirus vector containing human survivin gene and its expression in dendritic cells].

Zhu XP, Chen ZZ, Lin X, Hu JD, Li CT, Yang T, Xu ZS, Lü LL, Chen CP, Zhang LH. Zhu XP, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Aug;14(4):791-4. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006. PMID: 16928323 Chinese.

3

[Induction of anti-lymphoma cytotoxic T cell effect by dendritic cells transfected with recombinant adenovirus vectors carrying survivin gene].

Zhu XP, Chen ZZ, Hu JD, Li CT, Yang T, Xu ZS. Zhu XP, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Jun;15(3):591-3. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007. PMID: 17605872 Chinese.

4

In vitro inducing effect of dendritic cells cotransfected with survivin and granulocyte-macrophage colony-stimulating factor on cytotoxic T cell to kill leukemic cells.

Zhu XP, Chen ZZ, Li CT, Lin X, Zhuang JL, Hu JD, Yang T, Xu ZS. Zhu XP, et al. Chin Med J (Engl). 2008 Nov 5;121(21):2180-4. Chin Med J (Engl). 2008. PMID: 19080181

5

[Lethal effect of cytotoxic lymphocytes against U266 cells induced by DCs modified with GM-CSF gene and pulsed with tumour antigen].

Li CT, Zhu XP, Xu WQ, Xiao HF, Dong ZG. Li CT, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Aug;17(4):929-32. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 19698231 Chinese.

6

Serum-free media and the immunoregulatory properties of mesenchymal stem cells in vivo and in vitro.

Wu M, Han ZB, Liu JF, Wang YW, Zhang JZ, Li CT, Xin PL, Han ZC, Zhu XP. Wu M, et al. Cell Physiol Biochem. 2014;33(3):569-80. doi: 10.1159/000358635. Epub 2014 Feb 25. Cell Physiol Biochem. 2014. PMID: 24603109 Free article.

7

The dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits proliferation and induces apoptosis of burkitt lymphoma cells.

Li C, Xin P, Xiao H, Zheng Y, Huang Y, Zhu X. Li C, et al. Cancer Cell Int. 2015 Jun 24;15:65. doi: 10.1186/s12935-015-0213-1. eCollection 2015. Cancer Cell Int. 2015. PMID: 26130968 Free PMC article.

8

Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.

Xin P, Li C, Zheng Y, Peng Q, Xiao H, Huang Y, Zhu X. Xin P, et al. Among authors: li c. Drug Des Devel Ther. 2017 Apr 3;11:1115-1126. doi: 10.2147/DDDT.S132092. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28435223 Free PMC article.

9

[Effects of mTOR Inhibitor Rapamycin on Burkitt's Lymphoma Cells].

Zhou LH, Zhu XP, Xiao HF, Xin PL, Li CT. Zhou LH, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Oct;25(5):1397-1405. doi: 10.7534/j.issn.1009-2137.2017.05.020. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017. PMID: 29070114 Chinese.

10

[Silencing Calreticulin Expression Inhibits Invasion Ability of SNK6 Cells in Vitro via Down-Regulating Expression of VEGF and MMP2/9].

Zheng Y, Zhu XP, Li CT, Huang YL. Zheng Y, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Apr;27(2):433-438. doi: 10.19746/j.cnki.issn.1009-2137.2019.02.020. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019. PMID: 30998150 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89,328 results

Search Page

Filters